Trinity Biotech Plc - Company Profile
Powered by 
All the data and insights you need on Trinity Biotech Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Trinity Biotech Plc Strategy Report
- Understand Trinity Biotech Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Trinity Biotech Plc (Trinity Biotech) is a medical equipment company, which develops, acquires, manufactures, and distributes diagnostic systems for clinical laboratory and point-of-care market sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to detect hemoglobin A1c for diabetes monitoring and diagnosis, infectious diseases, autoimmune, sexually transmitted diseases, and liver and intestine disorders. It also offers raw materials to research and life sciences industries. Trinity Biotech markets its products through direct sales in the US, Brazil, Germany, France and the UK; and through a network of distributors and strategic partnerships in other countries. The company has manufacturing facilities in the US, Brazil, and Ireland. Trinity Biotech is headquartered in Wicklow, Ireland.
Headquarters
Ireland
Address
Ida Business Park, Bray, Co Wicklow, Ireland, 18
Website
www.trinitybiotech.com
Telephone
353 1 2769800
No of Employees
398
Industry
Medical Equipment
Ticker Symbol & Exchange
TRIB (NASD)
Revenue (2022)
$74.8M
-19.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-4786.7%
(2022 vs 2021)
Market Cap*
$14.0M
Net Profit Margin (2022)
XYZ
-5,934.0%
(2022 vs 2021)
* As of and is in US$
Trinity Biotech Plc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Point-of-Care: | - | - |
| Uni-Gold HIV | Laboratory Services | UniGold |
| Rapid Test Kits | Recombigen | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In January, the company entered into an agreement to acquire the biosensor and Continuous Glucose Monitoring assets of Waveform Technologies, Inc. |
| 2023 | Divestiture | In April, the company sold its Fitzgerald Industries life sciences supply business to Biosynth. |
| 2023 | Contracts/Agreements | In January, the company announced a strategic partnership with imaware to combines their built-to-partner digital health platform with the company’s advanced reference laboratory facilities to power the Digital Health Industry with at-home and remote testing programs. |
Competitor Comparison
| Key Parameters | Trinity Biotech Plc | Johnson & Johnson | Thermo Fisher Scientific Inc | Siemens Healthineers AG | Becton Dickinson and Co |
|---|---|---|---|---|---|
| Headquarters | Ireland | United States of America | United States of America | Germany | United States of America |
| City | Bray | New Brunswick | Waltham | Erlangen | Franklin Lakes |
| State/Province | - | New Jersey | Massachusetts | Bayern | New Jersey |
| No. of Employees | 398 | 152,700 | 130,000 | 71,400 | 73,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John Gillard | Chief Executive Officer; President | Senior Management | 2023 | 42 |
| Gary Keating, Ph.D | Chief Technology Officer | Senior Management | 2022 | 50 |
| Des Fitzgerald | Chief Financial Officer - Interim | Senior Management | 2023 | - |
| Jim Walsh, Ph.D. | Director | Executive Board | 2010 | - |
| John Mee | Director - Supply Chain | Senior Management | - | 59 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer